Spotlight on OHE: Value Footprint of Oncology Treatments, Treating Obstructive Sleep Apnoea and Sources of Motivation in Health Care Organisations
The blog provides links to slide sets and posters relating to the value footprint of oncology treatments, treating obstructive sleep apnoea and sources of motivation in health care organisations. The Expanding Value Footprint of Oncology Treatments Speaking at the Spanish…
The blog provides links to slide sets and posters relating to the value footprint of oncology treatments, treating obstructive sleep apnoea and sources of motivation in health care organisations.
The Expanding Value Footprint of Oncology Treatments
Speaking at the Spanish Health Economists Association Annual Meeting in Granada, Spain, 17-19th June 2015, OHE’s Jorge Mestre-Ferrandiz delivered a presentation on the expanding value footprint of oncology treatments.
Jorge’s presentation noted that cancer drugs tend to be more expensive than those used in most other therapeutic areas, and at the time of initial regulatory approval, the health gains from the use of new cancer drugs are often seen as being quite modest. Yet, many new cancer drugs have a therapeutic potential well beyond their initial indication. The objective of this study was to provide a better understanding of how changes in the use of an oncology medicine can affect the aggregate value of the treatment.
The Economic Consequences of Treating OSA in the UK
OHE’s Juan Carlos also presented a poster at the Spanish Health Economists Association Annual Meeting. The poster provided a summary of an empirical study into the economic consequence of treating obstructive sleep apnoea (OSA) in the UK.
The study found that OSA patients, the NHS and the wider society in the UK have not yet obtained all the economic and health benefits that could be achieved. An increase in the rate of uptake of continuous positive airway pressure (CPAP) could double the savings to the NHS and the health benefits to patients compared to current practice.
Incentives and Intrinsic Motivation in Health Care Organizations: a Case Study from Servicio Navarro de Salud-Osasunbidea
OHE’s Mikel Berdud delivered a presentation at the iHEA 11th World Congress in Health Economics held in Milan, Italy, 12-15th July 2015.
The presentation looked at how incentive schemes and policies which have been used to motivate physicians in recent decades may have crowded out1 doctors’ intrinsic motivation2 (IM), thereby provoking opportunistic behaviours and the opposite results from what was desired or expected. Mikel presented results of an interview based qualitative analysis which explored doctors’ intrinsic motivation, crowding-out effects of current incentive schemes, and potential ways to design incentives that may incentivise performance and improve doctors’ IM.
1 Crowding out is when rewards or incentives substitute individuals’ intrinsic motivation 2 Intrinsic motivation can be defined as doing something because is inherently interesting or enjoyable rather than for some separable consequence
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!